Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Botulinum Neurotoxin (BoNT)
100%
Randomized pilot Trial
100%
Dynamic Splint
100%
Elbow Extension
75%
Hypertonia
75%
Control Subjects
50%
Range of Motion
50%
Elbow Flexion
50%
Spasticity
50%
Adjunct Therapy
50%
Active Range of Motion
50%
Modified Ashworth Scale
50%
Manual Therapy
50%
Scale Extension
50%
Standard of Care
25%
Randomized Trial
25%
Flexion
25%
Patient-completed
25%
Upper Extremity
25%
Injection Therapy
25%
Contracture Reduction
25%
Tone Management
25%
Dynasplint
25%
Occupational Therapy
25%
Medicine and Dentistry
Range of Motion
100%
Botulinum Toxin A
100%
Splinting
100%
Muscle Hypertonia
75%
Spasticity
50%
Manual Therapy
50%
Apoplexy
25%
Elbow Flexion
25%
Upper Limb
25%
Contracture
25%
Occupational Therapy
25%
Occupational Medicine
25%
Secondary Condition
25%
Nursing and Health Professions
Pilot Study
100%
Botulinum Toxin A
100%
Splinting
100%
Muscle Hypertonia
75%
Spasticity
50%
Manipulative Medicine
50%
Efficacy
50%
Health Care Quality
25%
Cerebrovascular Accident
25%
Contracture
25%
Occupational Therapy
25%
Pharmacology, Toxicology and Pharmaceutical Science
Botulinum Toxin A
100%
Muscle Hypertonia
75%
Spasticity
50%
Cerebrovascular Accident
25%
Contracture
25%
Neuroscience
Botulinum Toxin A
100%
Cerebrovascular Accident
25%
Elbow Flexor
25%